Northern Trust Corp Ionis Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Northern Trust Corp holds 742,904 shares of IONS stock, worth $27.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

742,904

Previous 717,975 3.47%

Holding current value

$27.1 Million

Previous $34.2 Million 13.03%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$40.06 - $51.86 $998,655 - $1.29 Million	24,929 Added 3.47%	742,904 $29.8 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $937,785 - $1.23 Million	25,728 Added 3.72%	717,975 $34.2 Million
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $179,089 - $228,176	4,261 Added 0.62%	692,247 $30 Million
Q4 2023 Feb 13, 2024	SELL	$43.39 - $51.63 $118,801 - $141,362	-2,738 Reduced 0.4%	687,986 $34.8 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $756,371 - $925,915	19,646 Added 2.93%	690,724 $31.3 Million
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $438,014 - $546,477	12,612 Added 1.92%	671,078 $27.5 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $630,531 - $773,612	18,777 Added 2.94%	658,466 $23.5 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $595,738 - $746,599	16,049 Added 2.57%	639,689 $24.2 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $66,941 - $89,145	-1,832 Reduced 0.29%	623,640 $27.6 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $731,296 - $991,666	-23,062 Reduced 3.56%	625,472 $23.2 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $369,197 - $457,666	-12,356 Reduced 1.87%	648,534 $24 Million
Q4 2021 Feb 08, 2022	BUY	$25.61 - $35.1 $140,061 - $191,961	5,469 Added 0.83%	660,890 $20.1 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $541,738 - $654,963	-16,152 Reduced 2.41%	655,421 $22 Million
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $5.86 Million - $8.01 Million	-169,572 Reduced 20.16%	671,573 $26.8 Million
Q1 2021 May 12, 2021	BUY	$42.51 - $63.78 $678,927 - $1.02 Million	15,971 Added 1.94%	841,145 $37.8 Million
Q4 2020 Feb 11, 2021	SELL	$45.3 - $60.27 $288,198 - $383,437	-6,362 Reduced 0.77%	825,174 $46.7 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $44,555 - $59,110	939 Added 0.11%	831,536 $39.5 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $229,377 - $298,900	-4,896 Reduced 0.59%	830,597 $49 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $1.55 Million - $2.36 Million	37,206 Added 4.66%	835,493 $39.5 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $52,288 - $63,377	-971 Reduced 0.12%	798,287 $48.2 Million
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $392,099 - $479,003	-6,639 Reduced 0.82%	799,258 $47.9 Million
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $9.52 Million - $13.2 Million	153,326 Added 23.5%	805,897 $51.8 Million
Q1 2019 May 13, 2019	BUY	$52.92 - $81.17 $305,930 - $469,243	5,781 Added 0.89%	652,571 $53 Million
Q4 2018 Feb 12, 2019	BUY	$43.37 - $59.54 $285,287 - $391,654	6,578 Added 1.03%	646,790 $35 Million
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $796,238 - $997,155	18,569 Added 2.99%	640,212 $33 Million
Q2 2018 Sep 18, 2018	SELL	$40.53 - $50.7 $330,684 - $413,661	-8,159 Reduced 1.3%	621,643 $25.9 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $1.19 Million - $1.49 Million	29,445 Added 4.9%	629,802 $26.2 Million
Q1 2018 May 09, 2018	BUY	$44.08 - $55.05 $589,570 - $736,293	13,375 Added 2.28%	600,357 $26.5 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $221,118 - $283,058	-4,396 Reduced 0.74%	586,982 $29.5 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $26.9 Million - $35.2 Million	591,378	591,378 $30 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Ionis Pharmaceuticals Inc Transaction History